-
Mashup Score: 2
Rensselaer Polytechnic Institute’s Christopher Cioffi, Ph.D., Thomas and Constance D’Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Columbia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease — both blindness-causing diseases.
Source: news.rpi.eduCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 4Scientists 3D-print hair follicles in lab-grown skin - 2 year(s) ago
A team led by scientists at Rensselaer Polytechnic Institute has 3D-printed hair follicles in human skin tissue cultured in the lab. This marks the first time researchers have used the technology to generate hair follicles, which play an important role in skin healing and function.
Source: news.rpi.eduCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Mothers of Children With Autism Found to Have Significantly Different Metabolite Levels - 5 year(s) ago
January 13, 2021 Blood sample analysis showed key differences in several groups of metabolites Blood sample analysis showed that, two to five years after they gave birth, mothers of children with autism spectrum disorder (ASD) had several significantly different metabolite levels compared to mothers of typically…
Source: news.rpi.eduCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 1Rensselaer, GE Research, Cleerly, and Cornell Partner With NIH To Improve Cardiac CT Diagnosis - 5 year(s) ago
October 13, 2020 $3.7 million NIH grant supports AI developments to improve accuracy of diagnosis and reduce need for patients to undergo more costly and invasive procedures Heart disease is the leading cause of death worldwide for men and women. The most common type of heart disease, coronary artery disease, is…
Source: news.rpi.eduCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 3
In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease.
Source: news.rpi.eduCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3
A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.
Source: news.rpi.eduCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
April 20, 2020 NSF RAPID grant to support research effort to equip N95 masks with antiviral properties TROY, N.Y. — An interdisciplinary team of engineers from Rensselaer Polytechnic Institute is answering a national call for solutions to the shortage of personal protective equipment (PPE) available in the fight…
Source: news.rpi.eduCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Virtual Bariatric Endoscopic Training Tool Being Developed To Improve Patient Safety - 5 year(s) ago
March 10, 2020 NIH grant supports continued effort to train endoscopists through virtual reality simulation TROY, N.Y. — Finding safe solutions for the millions of adults in the United States who are battling obesity could vastly improve human health. According to the U.S. Centers for Disease Control and…
Source: news.rpi.eduCategories: Future of MedicineTweet
#NEIfunded researchers from @RPI and @Columbia are working to develop a drug to stabilize the retinol binding protein 4/Transthyretin complex. Read how this could improve treatment for diseases like #AMD and #Stargardt's: https://t.co/tEr3Rhyhee #VisionHealth https://t.co/W3Jx3A5KZy